MJardin Group Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on MJardin Group's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals Industry Growth | 6.0% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 30 Sep 2021 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How MJardin Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 21 | 6 | -56 | 10 | 0 |
| 30 Jun 21 | 10 | -27 | 15 | 0 |
| 31 Mar 21 | 11 | -27 | 16 | 0 |
| 31 Dec 20 | 11 | -30 | 19 | 0 |
| 30 Sep 20 | 11 | -240 | 27 | 0 |
| 30 Jun 20 | 13 | -260 | 27 | 0 |
| 31 Mar 20 | 18 | -257 | 34 | 0 |
| 31 Dec 19 | 27 | -265 | 44 | 0 |
| 30 Sep 19 | 31 | -108 | 62 | 0 |
| 30 Jun 19 | 33 | -96 | 59 | 0 |
| 31 Mar 19 | 31 | -95 | 55 | 0 |
| 31 Dec 18 | 28 | -81 | 43 | 0 |
| 30 Sep 18 | 26 | -8 | 28 | 0 |
| 30 Jun 18 | 22 | -6 | 26 | 0 |
| 31 Mar 18 | 22 | -1 | 20 | 0 |
| 31 Dec 17 | 20 | 2 | 18 | 0 |
| 31 Dec 16 | 16 | -1 | 2 | 0 |
| 31 Dec 15 | 4 | -3 | 2 | 0 |
Quality Earnings: Insufficient data to determine if MJAR.F has high quality earnings.
Growing Profit Margin: Insufficient data to determine if MJAR.F's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if MJAR.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare MJAR.F's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if MJAR.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: MJAR.F has a negative Return on Equity (0%), as it is currently unprofitable.